SRIVASTAVA, Arun,ZHONG, Li,ZOLOTUKHIN, Sergei,ASLANIDI, George V.,AGBANDJE-MCKENNA, Mavis,VAN VLIET, Kim M.
申请号：
HK16105737.9
公开号：
HK1217730A
申请日:
2016.05.18
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
Disclosed are next-generation multi-mutated capsid protein-modified rAAV expression vectors, as well as infectious virions, compositions, and pharmaceutical formulations that include them. Also disclosed are methods of preparing and using these high transduction efficiency vector constructs in a variety of therapeutic applications including,as delivery agents for the treatment or amelioration of one or more diseases or abnormal conditions in an affected mammal usingand/orviral vector-based gene therapy protocols. Also disclosed are large-scale production methods for the multi-mutated, capsid-modified rAAV expression vectors, viral particles, and infectious virions, as well as use of the disclosed compositions in the manufacture of medicaments for use in a variety ofand/ortherapeutic methodologies.
